We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Fabricated Sterility Tests Earn Brassica Pharma a Warning Letter after Failed Inspection
Fabricated Sterility Tests Earn Brassica Pharma a Warning Letter after Failed Inspection
Brassica Pharma, a maker of sterile semi-solids, received an FDA Warning Letter for failure to test every batch for sterility as well as fabrication of test results for batches not tested, among other violations.